https://orcid.org/0000-0002-3762-0372
References
- Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–2038.
- Catrina AI, Svensson CI, Malmstrom V, et al. Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis. Nat Rev Rheumatol. 2017;13(2):79–86.
- Veale DJ, Orr C, Fearon U. Cellular and molecular perspectives in rheumatoid arthritis. Semin Immunopathol. 2017;39(4):343–354.
- Bustamante MF, Garcia-Carbonell R, Whisenant KD, et al. Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther. 2017;19(1):110.
- McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007;7(6):429–442.
- Vishnoi A, Rani S. MiRNA biogenesis and regulation of diseases: an overview. Methods Mol Biol. 2017;1509:1–10.
- Li D, Zhou Q, Hu G, et al. MiRNA-506 inhibits rheumatoid arthritis fibroblast-like synoviocytes proliferation and induces apoptosis by targetting TLR4. Biosci Rep. 2019;39(5):BSR20182500.
- Li J, Song Q, Shao L, et al. MiR-124a inhibits proliferation and invasion of rheumatoid arthritis synovial fibroblasts. Eur Rev Med Pharmacol Sci. 2018;22(14):4581–4588.
- Guo J, Du J, Fei D, et al. MiR152 inhibits rheumatoid arthritis synovial fibroblast proliferation and induces apoptosis by targeting ADAM10. Int J Mol Med. 2018;42(1):643–650.
- Cao W, Dai H, Yang S, et al. Increased serum miR-300 level serves as a potential biomarker of lipopolysaccharide-induced lung injury by targeting IkappaBalpha. Pharmazie. 2017;72(1):5–9.
- Jia H, Liu J, Han B. Reviews of interleukin-37: functions, receptors, and roles in diseases. Biomed Res Int. 2018;2018:3058640.
- Sharma S, Kulk N, Nold MF, et al. Bufler P: the IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines. J Immunol. 2008;180(8):5477–5482.
- Xu WD, Zhao Y, Liu Y. Insights into IL-37, the role in autoimmune diseases. Autoimmun Rev. 2015;14(12):1170–1175.
- Zhao PW, Jiang WG, Wang L, et al. Plasma levels of IL-37 and correlation with TNF-α, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis. PLOS One. 2014;9(5):e95346.
- Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Ann Rheum Dis. 2010;69(9):1580–1588.
- Lefevre S, Knedla A, Tennie C, et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med. 2009;15(12):1414–1420.
- Li GF, Qin YH, Du PQ. Andrographolide inhibits the migration, invasion and matrix metalloproteinase expression of rheumatoid arthritis fibroblast-like synoviocytes via inhibition of HIF-1alpha signaling. Life Sci. 2015;136:67–72.
- Lao M, Shi M, Zou Y, et al. Protein inhibitor of activated STAT3 regulates migration, invasion, and activation of fibroblast-like synoviocytes in rheumatoid arthritis. J Immunol. 2016;196(2):596–606.
- Huang Y, Shen XJ, Zou Q, et al. Biological functions of microRNAs: a review. J Physiol Biochem. 2011;67(1):129–139.
- Xue Z, Zhao J, Niu L, et al. Up-Regulation of MiR-300 promotes proliferation and invasion of osteosarcoma by targeting BRD7. PLOS One. 2015;10(5):e127682.
- Wang L, Yu P. MiR-300 promotes proliferation and EMT-mediated colorectal cancer migration and invasion by targeting p53. Oncol Rep. 2016;36(6):3225–3232.
- Chen Y, Guo Y, Li Y, et al. miR‑300 regulates tumor proliferation and metastasis by targeting lymphoid enhancer‑binding factor 1 in hepatocellular carcinoma. Int J Oncol. 2019;54(4):1282–1294.
- Cavalli G, Dinarello CA. Suppression of inflammation and acquired immunity by IL-37. Immunol Rev. 2018;281(1):179–190.
- Yang Z, Kang L, Wang Y, et al. Role of IL-37 in cardiovascular disease inflammation. Can J Cardiol. 2019;35(7):923–930.
- Mei Y, Liu H. IL-37: an anti-inflammatory cytokine with antitumor functions. Cancer Rep. 2019;2(2):e1151.
- Wang L, Wang Y, Xia L, et al. Elevated frequency of IL-37- and IL-18Rα-positive T cells in the peripheral blood of rheumatoid arthritis patients . Cytokine. 2018;110:291–297.
- Ye L, Jiang B, Deng J, et al. IL-37 alleviates rheumatoid arthritis by suppressing IL-17 and IL-17-Triggering cytokine production and limiting th17 cell proliferation. J Immunol. 2015;194(11):5110–5119.